RUN Form 144 Notice: Insider to Offer 10,927 Shares via UBS
Rhea-AI Filing Summary
Sunrun Inc. Form 144 discloses a proposed sale of 10,927 common shares through UBS with an aggregate market value of $122,715. The securities represent a very small portion of the company's capital base: 10,927 of 230,732,572 outstanding shares.
The shares were acquired on 01/02/2020 as a stock award from Sunrun Inc., and the filing lists an approximate sale date of 08/13/2025. No sales by the reporting person are reported for the prior three months. The notice does not name the individual for whose account the sale is to be made and provides no additional commentary.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider notice; proposed sale is immaterial relative to shares outstanding and unlikely to move valuation.
The Form 144 shows a proposed disposition of 10,927 common shares via UBS valued at $122,715 against 230.7 million shares outstanding, representing roughly 0.0047% of the float. The shares were granted as a stock award on 01/02/2020, indicating this is a post-grant sale rather than new issuance. With no prior three-month sales reported, the filing is a standard compliance notice under Rule 144 rather than a signal of material insider divestiture.
TL;DR: Disclosure meets procedural requirements, but the absence of the seller's name limits clarity for stakeholders.
The notice identifies the broker (UBS) and the acquisition method (stock award) but omits the name of the person for whose account the securities will be sold. That omission reduces transparency about insider intent, though the small size of the proposed sale mitigates governance concerns. No related-party sales in the prior three months are reported, and the filing includes the required repurchase representations.